SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW)
NEOT 1.919+4.3%Jan 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gerald Underwood who wrote (570)10/22/1998 12:38:00 AM
From: David M. Evans  Read Replies (1) of 705
 
Well the DG article is from July 1997, which should mean that all that is already in today's price <g>

Has anyone considered that the present runup is simply the stock reflecting a more accurate valuation, given its position? Typically companies nearing the conclusion of phase 2 clinicals are worth more than $50 million (some up to $300 million). I'd take a few more days like today over that crazy day earlier this year. The shorts won't be quite as willing to gamble when it moves in more leisurely increments.

NeuroInvestment can shed some light on this, no doubt. FWIW, $20 seems very reasonable - with a little further news and some future funding uncertainties removed $30+ is not outlandish, IMO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext